Viktor Roschke
Gründer bei Neuraly, Inc.
Vermögen: 2 Mio $ am 31.05.2024
Aktive Positionen von Viktor Roschke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Direktor/Vorstandsmitglied | - | - |
Unternehmenssekretär | - | - | |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Neuraly, Inc. provides healthcare services. The company was founded by Seulki Lee and Viktor Roschke in 2016 and is headquartered in Gaithersburg, MD. | Direktor/Vorstandsmitglied | 01.01.2016 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 | - | |
Gründer | 01.01.2016 | - | |
D&D Pharma Tech Co., Ltd.
D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology D&D Pharma Tech Co., Ltd. engages in drug research and development. It develops medicines for metabolic, degenerative brain, and fibrotic diseases. The company was founded by Seul-Ki Lee, Seong-Mook Im and Kang Choon Lee on November 28, 2014 and is headquartered in Suwon, South Korea. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Viktor Roschke
Ehemalige bekannte Positionen von Viktor Roschke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.01.2005 | 01.01.2005 |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Geschäftsführer | - | - |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Technik-/Wissenschafts-/F&E-Leiter | 05.07.2012 | - |
Corporate Officer/Principal | 10.09.2010 | - |
Ausbildung von Viktor Roschke
Novosibirsk State University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
2 | |
Südkorea | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sektoral
Health Technology | 5 |
Retail Trade | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
Health Technology |
Private Unternehmen | 5 |
---|---|
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Retail Trade |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Health Technology |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Neuraly, Inc. provides healthcare services. The company was founded by Seulki Lee and Viktor Roschke in 2016 and is headquartered in Gaithersburg, MD. | Commercial Services |
- Börse
- Insiders
- Viktor Roschke
- Erfahrung